Cost-effectiveness of hyperthermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III-IV ovarian cancer from a randomized controlled phase III trial in Korea (KOV-HIPEC-01)
Ji Hyun Kim, Sung-Youn Chun, Dong-Eun Lee, Yo Han Woo, Suk‐Joon Chang, Sang‐Yoon Park, Yoon Jung Chang, Myong Cheol Lim
Topics & Concepts
MedicineHyperthermic intraperitoneal chemotherapyRandomized controlled trialCost effectivenessOvarian cancerCohortReimbursementQuality-adjusted life yearOncologyInternal medicineSurgeryCancerCytoreductive surgeryHealth careEconomicsRisk analysis (engineering)Economic growthIntraperitoneal and Appendiceal MalignanciesOvarian cancer diagnosis and treatmentNeutropenia and Cancer Infections